PlainPharmaWatch

CMS Open Payments · Tool

Biocircuit Technologies Inc vs RedHill Biopharma Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Biocircuit Technologies Inc has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 3,424, versus 18 for the other company. Its single largest recorded recipient represents 56.1% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Biocircuit Technologies Inc
HHI 3,424 · top recipient 56.1%
Ranked #516 of 1,838 companies by HHI
RedHill Biopharma Inc.
HHI 18 · top recipient 0.8%
Ranked #1,820 of 1,838 companies by HHI

Payment Overview

Total Payments
$69.8K
% of Industry
0.0%
Transactions
112
Avg per Transaction
$622.81
Recipients
112
Avg per Recipient
$622.81
Payment Types
3
Top Payment Type
Consulting Fee
Total Payments
$68.8K
% of Industry
0.0%
Transactions
1,507
Avg per Transaction
$45.63
Recipients
1,502
Avg per Recipient
$45.78
Payment Types
1
Top Payment Type
Food and Beverage

Highlighted values indicate the higher figure for each metric.

Total payments compared

Biocircuit Technologies Inc vs RedHill Biopharma Inc. - total reported payments in CMS Open Payments PY2024

Biocircuit Technologies Inc$69.8KRedHill Biopharma Inc.$68.8K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Biocircuit Technologies Inc

Consulting Fee $55.6K

79.8%

Food and Beverage $8.0K

11.5%

Travel and Lodging $6.1K

8.8%

RedHill Biopharma Inc.

Food and Beverage $37.3K

100.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Biocircuit Technologies Inc

  1. 1

    JONATHAN ISAACS

    $39,148.67 · 16 txns

  2. 2

    LISA GFRERER

    $6,817.28 · 4 txns

  3. 3

    KYLE EBERLIN

    $6,500.00 · 5 txns

  4. 4

    STEVEN MORAN

    $5,000.00 · 4 txns

  5. 5

    ALANNA REBECCA

    $4,275.18 · 7 txns

RedHill Biopharma Inc.

  1. 1

    BRIDGET MARRIN

    $294.89 · 2 txns

  2. 2

    LING LEE

    $235.90 · 6 txns

  3. 3

    ERIC CHEUNG

    $213.90 · 5 txns

  4. 4

    DIANE NGUYEN DR

    $199.18 · 4 txns

  5. 5

    HOA NGUYEN DR

    $187.84 · 3 txns

Summary Comparison

Metric Biocircuit Technologies Inc RedHill Biopharma Inc.
Total Payments $69.8K $68.8K
% of Industry Total 0.0% 0.0%
Transaction Count 112 1,507
Avg per Transaction $622.81 $45.63
Recipient Count 112 1,502
Avg per Recipient $622.81 $45.78
Payment Type Count 3 1
Top Payment Type Consulting Fee Food and Beverage

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.